visibl rais pt
quest earn continu build support nation lab consolid
thesi import tenet ow invest recommend compani
highlight quarter report volum growth organ
volum growth came better expect organ volum
improv q/q view solid especi light commentari
compani walk away low-margin busi drag
revenu better forecast repres growth
y/i believ volum import near-term driver thesi
think favor result posit sentiment appear quest
remain good start volum growth follow expand access
manag care payor healthcar system increasingli focus cost valu
proposit believ nation lab leverag scale advantag
consolid share continu see lot payor activ encourag share shift
toward nation lab includ pln roll-out well
decis align rate hospit outreach lab independ lab peer histor
hospit reimburs premium adjust ep
better forecast due predominantli ebit beat capit
deploy quest repurchas stock paid dividend
quest maintain outlook believ earn beat
help take oper pressur prior ramp specif quest
continu expect adjust revenu billion repres
equival growth y/i quest continu expect headwind price
given increas pressur pama well shift in-network rate
adj ep expect greater compar
forecast believ build volum growth keep
focu consolid opportun nation lab given expand access
payor effort encourag adopt low-cost provid
reiter ow rate rais pt
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
overweight believ quest long
runway deliv strategi acceler growth
deliv oper excel point new
payor relationship help drive lab test share
toward nation lab time addit
believ quest meaning leverag
diagnost data asset custom
upsid case assum quest aggreg
increment test share drive upsid
case ep earn begin
acceler believ multipl room
expans well given long runway
downsid case assum softer util
well increment wage pressur busi
cost repres downsid
case ep
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
quest earn continu build support nation lab consolid
thesi import tenet ow invest recommend compani
highlight quarter report volum growth organ volum
growth came better expect organ volum improv
q/q view solid especi light commentari compani
walk away low-margin busi drag revenu
better forecast repres growth y/i believ volum
import near-term driver thesi think favor result
posit sentiment appear quest remain good start
volum growth follow expand access manag care payor healthcar
system increasingli focus cost valu proposit believ nation lab
leverag scale advantag consolid share continu see lot payor
activ encourag share shift toward nation lab includ pln
roll-out well decis align rate hospit outreach lab
independ lab peer histor hospit reimburs premium adjust
ep better forecast due predominantli
ebit beat capit deploy quest repurchas stock paid
quest maintain outlook believ earn beat help
take oper pressur prior ramp specif quest continu
expect adjust revenu billion repres equival growth
y/i quest continu expect headwind price given increas
pressur pama well shift in-network rate adj ep
expect greater compar forecast
believ build volum growth keep focu consolid
opportun nation lab given expand access payor effort
encourag adopt low-cost provid reiter ow rate rais
pt
action rais pt reiter ow
given build momentum payor access improv visibl quest
forecast rais price target price target
repres blend scenario analysi ep yield
multipl ep forecast prior pt repres
blend scenario analysi ep yield multipl ep
forecast
upsid downsid methodolog
epsmultipleoutcomerel pricenotesbas lab share revenue upsid epsdownsid volum wage pressur barclay quest diagnost
quest reiter guidanc initi earn quest expect
adjust revenu billion repres revenu growth y/i
within target believ quest target roughli organ growth
compani aim contribut acquisit quest embed
share gain payor contract chang guidanc compani quantifi
anticip tailwind compani provid tax rate interest rate expect
emb unannounc capit deploy estim
adj ep expect guid impli ep growth
least y/i embed ep guidanc greater million headwind
reimburs pressur believ stem larg pama
price declin addit quest expect gener cffo deploy
capital-expenditure
quest reiter comment phase ep guidanc million
reimburs headwind expect evenli spread throughout year quest
easi comparison a/r adjust creat headwind
one fewer revenu day one extra revenu day volum
contract chang expect build throughout year though compani
face increment cost support volum
quest report billion revenu quarter repres equival
growth y/i inc equival growth better estim
revenu laboratori test increas revenu decreas
y/i revenu per requisit decreas y/i vs forecast
number factor expect weigh rev-per-req includ pama
model unit price reduct well reset revenu
lower first quarter relat account receiv adjust taken
volum increas y/i stronger estim
adjust acquisit organ volum growth vs
forecast adjust tailwind expand payor access estim
tailwind estim calendar impact headwind estim underli
util increas roughli y/i would continu improv
quarterli revenu million organ growth
underli driver revenu growth quest
quest see earli sign share gain payor network chang expect
volum continu build throughout size quarterli tailwind
base assumpt match improv volum
growth quarter
growth y/i assumptionstot growth equival trial total test y/i lab organ total requisit y/i y/i organ net new weather calendar underli ppa per y/i y/i organ rev medicar pama overal y/i organ growth clinic dx rev pre- debt lab y/i y/i organ total barclay quest diagnost
cfo mark guinan commentari benefit expand payor access
look requisit per day apples-to-appl basi absolut continu grow throughout
quarter note close comment expect balanc year throughout
month begin year first quarter saw acceler volum growth throughout second
quarter look apples-to-appl comparison absolut continu strengthen despit basi
term market access unit obvious make us competit enabl us win offic
therefor see growth across board limit unit horizon
continu believ improv health plan access
other repres signific opportun quest view open
aetna network first time sinc opportun
quest labcorp consolid share fragment lab industri remind quest
labcorp announc new contract may
view game-chang industri previous quest labcorp exclus
relationship aetna respect open
sinc januari quest size share gain opportun around billion
compani think could drive upsid new long-term compound-annual-growth-rate
revenu earn new relationship
unitedhealthcar horizon georgia quest ad total
increment live quest believ market share plan
today goal reach share posit line commerci share
current in-network plan end given new live repres
billion revenu opportun share would impli billion revenu goal
payor next three year
look back believ origin sign exclus nation laboratori
contract labcorp quest nation payor ultim strateg
mistak addit pit two nation lab price
misalign network access also creat opportun region lab compet
equal foot given quest labcorp exclud
aetna contract respect nation lab could longer serv sole provid
physician offic allow region laboratori sell messag could
becom one stop shop help offic streamlin oper
allow lab like bio-refer enzo gain market share patient
creat opportun realiz pull-through revenu convert entir
physician offic enabl share gain volum cover insur
look forward believ implement unitedhealth prefer lab
network pln repres addit strateg posit labcorp quest
question continu debat meaning
remind pln origin announc decemb slate go
effect juli pln subset in-network provid
includ lab quest ameripath subsidiari labcorp bio-refer genedx
subsidiari cover invita cover mayo lab privat
believ cover full menu test given lab commentari mix routin
advanc test provid chang network statu lab
provid nation lab comment potenti econom
incent physician patient choos prefer provid lower out-of-
pocket expens benefit design chang view potenti event
announc addit detail payor prefer lab
network pln part payor may monthli network bulletin pln
ad layer prefer lab chang network statu lab
provid note prefer lab select given
met higher standard access cost data qualiti servic base rigor
applic review process addit ad prefer lab
network provid highlight directori start juli make easi
member care provid identifi
addit implement stiffer out-of-network restrict effect
address provid note out-of-network laboratori
referr creat excess cost health care system may pose potenti qualiti
risk patient help protect patient requir refer lab servic
particip lab provid follow requir appli unitedhealthcar
commerci plan except requir written consent member use out-
of-network laboratori includ indic member discuss option
use in-network lab inform potenti increas
out-of-pocket expens
decis addit provid must obtain
unitedhealth approv refer member use out-of-network lab
prior exclus contractsaet patientspost exclus contractsbio-refer labcorp questphysician officeaet patientsbio-refer enzophysician offic patientslabcorpphysician officeaet patientsscenarioscenario barclay quest diagnost
view opportun labcorp quest go depend
strength patient physician incent await addit visibl
lab strength incent order gaug
potenti share shift time perspect expect physician incent
implement juli pln offici kick believ pln could
includ chang benefit design chang would like take effect begin
follow year manag care sell cycl take place throughout
summer fall result expect labcorp quest see meaning
impact pln
commentari prefer lab network
overal commentari newli establish prefer laboratori network pln physician patient
like receiv better health care valu improv access qualiti servic lower cost creation
pln advanc way work select lab provid deliv care place greater emphasi patient
outcom total cost person care launch juli unitedhealthcar select follow lab
particip pln ameripath/dermpath biorefer genedx labcorp mayo clinic laboratori quest
diagnost lab select base rigor qualiti review process
patient incent chang lab access consum consum still use lab pln
howev choos lab pln may lead shorter wait time servic on-line schedul patient servic
center higher qualiti care lower cost
physician incent expect physician refer lab pln notic prompt turn-around time lab
result ease-of-us order lab electron well easi access physician-to-lab medic director
consult support patient care need anyth differ access servic provid
particip pln design unitedhealthcar provid directori
quest activ new acquisit partnership divestitur
continu see signific runway consolid laboratori test
beyond continu believ effort provid better healthcar integr
patient cost share greater regul fda ldt reimburs pressur
pama driver share consolid toward effici provid quest
labcorp organ growth modest compani done effect
job win new busi hospit partnership acquisit compani
spent million million full-year
quest first excit part prefer lab network mention comment two seven tight network start juli howev word know word announc back network last year quit lot interest nation payer mean larg region needless say think begin trend would like continu see relationship mean becom clear get indic clearli incent physician patient benefit design move volum high-valu lab provid like quest diagnost prefer lab network initi obvious middl year likelihood signific impact in-year think minim built anyth volum guidanc would anticip signific impact think go manag care sell cycl summer fall see implement januari lot go depend prefer lab network tie benefit design out-of-network benefit benefit employ push employe prefer lab network benefit design prefer lab network well tie togeth long term signific opportun us barclay quest diagnost
believ reimburs pressur drive lab consolid smaller competitor
lack scale drive effici busi margin come increas
pressur quest announc seven partnerships/d mark acceler
rel recent year compani less activ begin though recent
announc new deal quest vocal robust pipelin potenti deal
compani expect growth deal provid larger impact
state guidanc transact improv visibl top line growth
help off-set price headwind pama quest organ hospit relationship
two strategi
profession lab servic pl quest work hospit offer lab manag
servic within hospit inpati outpati procedur area save
includ refer work integr quest test network procur save
quest purchas scale employe manag product improv
contract negoti hospit way allow hospit save
money quest make margin inpati outpati test
servic typic bundl part drg code given procedur reimburs
medicar part ipp opp respect hospit
unwil part lab ownership give quest opportun
gener instant save reson new relationship notabl
shown chart quest announc pl arrang barnaba
new jersey hca one hospit network denver montefior
outreach acquisit absent integr deal quest activ
acquisit hospit outreach test hospit outreach compet directli
two nation lab busi gener physician offic altern site
follow acquisit hospit lab revenu get reset lower onto labcorp
quest fee schedul major payor sizabl reduct
greater despit rate reset nation lab believ abl drive
signific effici still achiev ebitda margin mid-teen
independ affili barclay quest diagnost
 clinic laboratori acquisit partnership
pleas see report
quest continu believ pama creat meaning headwind medicar
reimburs quest quot headwind pama
repres cut lab revenu tie medicar clf
remind implement pama kick largest chang diagnost
reimburs year result confirm belief pama lead
meaning medicar cut time lead period heighten lab industri
consolid pama expect serv headwind compani
medicar revenu financi impact still meaning yet
manag given medicar clf repres quest revenu
assum drop-through price reduct equat ep
headwind medicar reimburs chang actual
sizabl survey work interact lab director suggest industri
experi period meaning consolid ultim believ smaller lab
outsiz medicar exposur consolid time either organ
inorgan benefit labcorp quest industri leader
potenti off-set horizon data collect
process similar process two import chang relat
definit applic lab influenc survey pool first chang
medicar advantag revenu exclud total medicar revenu threshold
second signific chang enabl hospit lab without uniqu npi
applic lab medicar revenu meet major
medicar revenu low expenditur threshold decis broaden definit
includ hospit lab come receiv much critic limit
hospit lab particip previou pama survey even addit hospit lab
particip still expect labcorp quest repres vast major data
submit part survey routin test though broader particip could
limit risk around addit cut clear chang view
expect medicar rate cut pama rate lock
data report period remind data report take place everi
yeardealslabtarget/partnerdatetyp medic center rmc orangeburg bynum patholog laboratori lab gener outreach medic outreach lab acquisitionquestoxford immunotec us lab lab lab acquisitionlabcorpappalachian region servicesquestcalifornia laboratori associ outreach acquisitionquestcleveland clinic servicesquesthartford outreach acquisitionquestshiel medic laboratori jvquestcap cod care outreach acquisitionquestm fusion associ medic laboratori laboratori outreach acquisit servicessonicwestern connecticut network venturequestmontefior serviceslabcorpmount acquisit barclay quest diagnost
year said think market may view posit given potenti
rate increas relief futur cut current model addit cut
top hcpc code clf spend
make adjust weather calendar impact acquisit new
busi underli util appear strengthen overal volum
grew quarter emb contribut acquisit sever
deal contribut growth addit estim volum benefit
due share gain unitedhealthcar horizon bcb georgia net aetna
weather impact quarter estim calendar
volum headwind follow adjust estim underli util
y/i q/q quest encourag volum tb
quantiferon t-spot cardio test
hcpc codehcpc code descriptiontot claim linestot payment total nlaweight median payment w/ payment w/ payment w/ thyroid stim metabol cbc w/auto diff hemoglobin test def panel total test def parathormon psa free culture/coloni test def test def natriuret colorect breast cbc folic acid suscept barclay quest diagnost
note organ volum growth adjust labcorp base estim
note organ adjust volum growth adjust weather notabl net new busi calendar labcorp base estim
revenu per requisit compris unit price variat busi mix test mix
quest note pama includ clf medicaid commerci link pressur
headwind rev-per-req line prior expect total unit price
headwind pama headwind impli headwind payor
notabl switch in-network unitedhealthcar quest
note patient concess improv sequenti impli headwind
magnitud headwind quest continu
expect price headwind greater
note organ reimburs growth adjust fx beacon lb labcorp adjust mix labcorp base estim
sg ex- stock comp percentag revenu y/i
q/q sg expect revenu
stock-bas comp million came lower estim
sg trend revenu
adjust ebit ex-amort decreas y/i million
estim million oper margin weaken y/i
came forecast remind quest expect see
margin impact aforement price pressur off-set cost reduct
adj margin trend revenu
cffo solid million though came estim million
differ driven work capit use vs model
repres adj net incom quarter capital-expenditure million
repres revenu estim million addit
quest deploy million dividend sharehold final compani also
repurchas share quarter quest continu gener signific
free cash flow priorit toward tuck-in estim compani
exit net debt ttm ebitda par histor level
use oper million
million except per share dataestestestestestestincom increas debt debt debt gross lab increas equival organ increas net margin net sg net comp sg net increas intang oper ebitda margin net oper profit ebit margin net interest expens debt share earn joint expens pre-tax pre-tax provis incom tax net net average share average share ep ep increas item net net increas ens net incom growth net ep growth ebit adj ebit margin net adj ebit margin gross barclay quest diagnost
 mm except ep reportedincom growth ebitda ebit pre-tax tax net adj net researchprior yearprior quarter barclay
meehan cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
